WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018129400) METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISORDER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/129400 International Application No.: PCT/US2018/012694
Publication Date: 12.07.2018 International Filing Date: 05.01.2018
IPC:
A61K 39/395 (2006.01) ,A61P 11/00 (2006.01)
Applicants: ALLAKOS INC.[US/US]; 75 Shoreway Road, Suite A San Carlos, CA 94070, US
Inventors: YOUNGBLOOD, Bradford, Andrew; US
TOMASEVIC, Nenad; US
BEBBINGTON, Christopher, Robert; US
Agent: JONES, Kevin; US
ARJOMAND, Mehran; US
AIKEN, Charity; US
AN, Na; US
AHN, Sejin; US
Priority Data:
62/443,59106.01.2017US
Title (EN) METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISORDER
(FR) MÉTHODES ET COMPOSITIONS POUR TRAITER UN TROUBLE PULMONAIRE OBSTRUCTIF CHRONIQUE
Abstract: front page image
(EN) The present disclosure provides methods for the treatment of chronic obstructive pulmonary disease (COPD) (e.g., non-eosinophilic COPD). In particular, the present disclosure provides methods for the treatment of COPD (e.g., non-eosinophilic COPD) through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of COPD (e.g., non-eosinophilic COPD).
(FR) La présente divulgation concerne des méthodes destinées à traiter une maladie pulmonaire obstructive chronique (MPOC) (par exemple, MPOC non à éosinophiles). En particulier, la présente divulgation concerne des méthodes destinées à traiter une MPOC (p. ex., MPOC non à éosinophiles) par administration d'anticorps qui se lient à la Siglec-8 humaine ou de compositions les contenant. Des articles manufacturés ou des kits comprenant des anticorps qui se lient à la Siglec-8 humaine pour traiter une MPOC (p. ex., MPOC non à éosinophiles) sont en outre décrits.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)